ENTRY       D10882            Mixture   Drug
NAME        Daclatasvir, asunaprevir and beclabuvir;
            Ximency (TN)
COMPONENT   (Daclatasvir dihydrochloride [DR:D10105] | Daclatasvir [DR:D10065]), Asunaprevir [DR:D10093], (Beclabuvir hydrochloride [DR:D10611] | Beclabuvir [DR:D10610])
CLASS       Antiviral
             DG03198  Anti-HCV agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
             DG02856  SLCO1B1 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
             DG02907  SLCO1B3 inhibitor
REMARK      ATC code: J05AP58
EFFICACY    Antiviral
COMMENT     Daclatasvir is a substrate of CYP3A4 and P-glycoprotein (P-gp) , and it is an inhibitor of the following transporters: P-gp, OATP1B1, OATP1B3 and BCRP.
            Asunaprevir is a substrate of CYP3A, P-gp and OATP1B1, and it is an inhibitor of CYP2D6, OATP1B1, OATP1B3 and P-gp and a inducer of CYP3A4.
            Beclabuvir is a substrate of CYP3A, P-gp and BCRP, and it is an inhibitor of P-gp, BCRP, OATP1B1 and OATP1B3 and a inducer of CYP3A4.
TARGET      HCV NS3/4A protease [KO:K22273 K22274]
            HCV NS5A [KO:K22275]
            HCV NS5B [KO:K22472]
  PATHWAY   ko03230(K22273+K22274+K22275+K22472)  Viral genome structure
            ko03240(K22273+K22274+K22275+K22472)  Viral replication
            ko05160(K22273+K22274+K22275+K22472)  Hepatitis C
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
            Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599]
INTERACTION CYP induction: CYP3A4 [HSA:1576]
            Transporter inhibition: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AP Antivirals for treatment of HCV infections
                 J05AP58 Daclatasvir, asunaprevir and beclabuvir
                  D10882  Daclatasvir, asunaprevir and beclabuvir
            Drug groups [BR:br08330]
             Antiviral
              DG03198  Anti-HCV agent
               D10882  Daclatasvir, asunaprevir and beclabuvir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10882  Daclatasvir, asunaprevir and beclabuvir
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                D10882  Daclatasvir, asunaprevir and beclabuvir
             Transporter substrate
              DG01665  ABCB1 substrate
               D10882  Daclatasvir, asunaprevir and beclabuvir
              DG01913  ABCG2 substrate
               D10882  Daclatasvir, asunaprevir and beclabuvir
              DG02856  SLCO1B1 substrate
               D10882  Daclatasvir, asunaprevir and beclabuvir
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D10882  Daclatasvir, asunaprevir and beclabuvir
              DG02862  ABCG2 inhibitor
               D10882  Daclatasvir, asunaprevir and beclabuvir
              DG02865  SLCO1B1 inhibitor
               D10882  Daclatasvir, asunaprevir and beclabuvir
              DG02907  SLCO1B3 inhibitor
               D10882  Daclatasvir, asunaprevir and beclabuvir
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HCV NS3/4A inhibitor
                D10882  Daclatasvir, asunaprevir and beclabuvir
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10882
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10882
             Drug transporters
              D10882
DBLINKS     PubChem: 328082974
///
